Anaptysbioincis A Clinical Stage Biotechnology Company Based In San Diegocaliforniafounded In 2005 And Publicly Traded On Nasdaq Under The Symbol Anab Since 2017The Company Focuses On Developing Immune Cell Modulating Antibodies For Autoimmune And Inflammatory Diseaseswith A Team Of Approximately 136 Employeesanaptysbio Is Dedicated To Advancing Therapeutic Antibodies Through Various Stages Of Preclinical And Clinical Development The Company S Core Therapeutic Focus Includes Conditions Such As Rheumatoid Arthritis And Ulcerative Colitisanaptysbio S Research Platform Generates Antibodies That Target Immune Checkpoints And Cytokine Receptors To Help Restore Immune Balancetheir Product Pipeline Features Several Candidatesincluding Rosnilimabanb033Anb101Imsidolimaband Anb032Which Are In Various Stages Of Development For Different Indicationsanaptysbio Also Engages In Strategic Collaborations With Major Pharmaceutical Companies To Enhance Its Research And Development Efforts
